• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    More On TTH.TO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Transition Therapeutics Inc. (TTH.TO)

    -Toronto
    2.83 0.00(0.00%) Jul 30
    Add to Portfolio
    Prev Close:2.83
    Open:3.00
    Bid:2.65
    Ask:2.90
    1y Target Est:N/A
    Beta:0.66
    Earnings Date:Sep 14 - Sep 18 (Est.)
    Day's Range:2.83 - 3.00
    52wk Range:2.50 - 11.50
    Volume:1,000
    Avg Vol (3m):11,072
    Market Cap:109.97M
    P/E (ttm):N/A
    EPS (ttm):-1.45
    Div & Yield:0.06 (0.20%)
    Quotes delayed, except where indicated otherwise. Currency in CAD.

    Headlines

    » More Headlines for TTH.TO

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:29-Dec-10

    Analysts

    Annual EPS Est (Jun-15) :-1.22
    Quarterly EPS Est (Jun-15) :N/A
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications in Canada. The company's lead central nervous system drug candidate is ELND005, a Phase II clinical trial product us... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback